AETNA INC /PA/
Item 1. Business
We are one of the nation's leading diversified health care benefits companies, serving an estimated 44 million people with information and resources to help them in consultation with their health care professionals make better informed decisions about their health care. We offer a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid health care management services, Medicare Advantage and Medicare supplement plans, workers' compensation administrative services and health information technology products and services, such as Accountable Care Solutions (“ACS”). On May 7, 2013, we acquired Coventry Health Care, Inc. (“Coventry”). The acquisition enhances the scope and geographic breadth of our Health Care products. Our customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (“providers”), governmental units, government-sponsored plans, labor groups and expatriates.
We are working to build healthier communities, a healthier nation and a healthier world. Our operational, financial and strategically important accomplishments during 2013 included:
•
Completing the acquisition of Coventry in a transaction valued at approximately $8.7 billion, including the assumption of Coventry's outstanding long-term debt. The Coventry acquisition:
•
Added medical membership which enhanced our diversified portfolio.
•
Increased our presence in government programs, which is an important element of our growth strategy.
•
Improved our positioning and reach in local geographies.
•
Making progress in growing our next generation network strategy, including our ACS products, patient centered medical homes and other value-based network arrangements. We continue to execute on our strategy of transforming the provider network model and in turn making quality health care more accessible and affordable, which is important in an environment where consumers are focused on receiving quality care at a low cost. Using our combination of population health management technologies and medical management capabilities, our goal is to continue to be a leader in enabling health care providers to change their business models from episodic acute care to patient population management, which allows them to convert from volume-based reimbursement to value-based reimbursement and lowers medical costs for us and our customers, making our products more affordable. In 2013, we signed 17 new accountable care organization (“ACO”) collaborative agreements, bringing our total ACO collaborative agreements to 32 serving 550 thousand ACO members.
•
Making progress in developing and implementing our public health insurance exchange (“Public Exchange”) and private health insurance exchange (“Private Exchange”) strategies. For 2014, Aetna currently has chosen to participate in 10 statewide individual Public Exchanges and, on a limited basis, an additional seven states' individual Public Exchanges. Additionally, in 2014, Aetna currently has chosen to participate in three statewide small group Public Exchanges and, on a limited basis, one additional state's small group Public Exchange. We also are participating in a number of Private Exchanges in 2014. We believe that Private Exchanges are an efficient way for plan sponsors to shift towards a defined contribution model for employee health benefits.
•
Expanding our presence in government programs, through the acquisition of Coventry, as well as underlying Medicare Advantage and Medicare Supplement membership growth. We continue to believe that Medicare products can be a valuable part of our earnings profile over the long term.
•
Effectively deploying excess capital to deliver value for shareholders, as we repurchased 23.0 million shares and raised our quarterly shareholder dividend by approximately 13 percent to $.225 per common share.
We believe that these accomplishments strategically position us for future success with the goal of participating in the shaping of more effective health care systems.
The health care industry continues to experience significant change. The Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (collectively, “Health Care Reform”) has changed and will continue to make broad-based changes to the U.S. health care system which could significantly
affect the U.S. economy and we expect will continue to significantly impact our business operations and financial results, including our pricing, our medical benefit ratios and the geographies in which our products are available. Health Care Reform presents us with new business opportunities, but also with new financial and regulatory challenges. Key components of the legislation will continue to be phased in through 2018, with the most significant changes during that time occurring in 2014, including significant new industry-wide fees, assessments and taxes, Public Exchanges (also known as health insurance marketplaces), Medicare minimum medical loss ratios (“MLRs”), the individual coverage mandate, guaranteed issue and rating limits in the individual and small group markets. It is reasonably possible that Health Care Reform, in the aggregate, could have a material adverse effect on our business operations and financial results. For additional information on federal and state health care reform, refer to “Overview” and “Regulatory Environment” and for a discussion of certain factors that may cause our actual results to differ from currently anticipated results in connection with health care reform, see “Forward-Looking Information/Risk Factors,” each sections of the Management's Discussion and Analysis of Financial Condition and Results of Operations (the “MD&A”), beginning on pages 2, 29 and 46 of the Annual Report, respectively, which are incorporated herein by reference.
In addition, employers, consumers and the federal and state governments continue to increase their focus on health care costs, and federal and state governments continue to increase their focus on providing health insurance to the uninsured; and they continue to drive changes in the structure of health insurance and related benefits products and services. Product features continue to evolve that are directed at containing rising health care costs, addressing affordability problems, enhancing access to quality health care services and giving members greater control and responsibility in directing their benefit dollars. For employer-based health coverage, employers are continuing to require covered employee members to assume a greater portion of the cost of their health care and/or coverage. These economic and political factors and greater consumer awareness are leading to increased popularity of products that offer flexibility in design features such as deductibles and co-payments, health savings accounts, consumer access to a broader network of health care providers, quality-based physician networks and high value network solutions. The industry is also subject to other forces including adverse and uncertain economic conditions in the U.S. and abroad, federal and state legislative and regulatory reforms, the shift towards a consumer-focused retail marketplace, advances in pharmaceutical and medical technology and industry consolidation. All of these factors can affect the competitiveness of product and service offerings, the range of industry competitors and the bases of competition. We believe that these factors will exist for some time and will drive a continuing evolution in the health care and related benefits industry.
We continue to invest in our company through the development of new products, strategic acquisitions and new business alliances. We place significant emphasis on developing and maintaining our product and service offerings to serve existing and new customer markets and have done so through organic growth, acquisitions, such as the acquisition of Coventry, and new business alliances, such as our ACO arrangements.
Over the last five years, this focus has led to the introduction of new products and tools, such as our HealthagenSM portfolio of products, including our ACS, ActiveHealth and Medicity Inc. (“Medicity”) health information technology (“HIT”) solutions, which further enhance our strategy of transforming the provider network model and in turn making health care more accessible and affordable; CarePass®, which provides consumers with important tools which help to make healthcare more convenient, connect them to providers, and help them navigate the evolving health care system; Aetna One®, our suite of integrated products such as disease management and prevention, wellness and health promotion, and health, disability and absence assessments, designed to help improve member health and productivity and lower medical and other benefit cost trend over time; and Aetna Vision PreferredSM, which provides members with access to one of the largest vision networks in the U.S. We also continue to develop and enhance our existing products and are continuing to expand our initiative to improve the transparency of our products and pricing.
Acquisition of Coventry
On May 7, 2013 (the “Effective Date”), we acquired Coventry in a transaction valued at approximately $8.7 billion, including the assumption of Coventry's outstanding long-term debt. Coventry's products included a full portfolio of risk and fee-based products, including Medicare Advantage and Medicare Part D programs, Medicaid managed care
plans, group and individual health insurance, coverage for specialty services such as workers' compensation administrative services, and network rental services.
The Coventry acquisition added medical membership, which enhanced our diversified portfolio, increased our presence in government programs, which is an important element of our growth strategy, and improved our positioning and reach in local geographies.
In connection with the acquisition of Coventry, on March 31, 2013, we completed the sale of our Missouri Medicaid business, Missouri Care, Incorporated (“Missouri Care”), to WellCare Health Plans, Inc. The sale price was not material and did not have a material impact on our financial position or operating results.
Other Transactions
In November 2013, we entered into a definitive agreement to acquire InterGlobal group, a company that specializes in international private medical insurance for groups and individuals in the Middle East, Asia, Africa and Europe. The purchase price is not material. We expect to complete the transaction in the first half of 2014 and finance the acquisition using available resources.
During 2011, we completed four acquisitions that added capabilities and membership, and further advanced our strategies. These acquisitions are further described below in the discussion of our Health Care products and services.
Our operations are conducted in three business segments: Health Care, Group Insurance and Large Case Pensions. We derive our revenues primarily from insurance premiums, administrative service fees, net investment income and other revenue. Refer to the MD&A and Note 19 of Notes to Consolidated Financial Statements beginning on pages 2 and 135, respectively, of the Annual Report, which are incorporated herein by reference, regarding revenue, profit and total asset information for each of our business segments and revenue and asset information about geographic areas. Coventry's business and related financial results on and after the Effective Date are recorded within our Health Care segment. The following is a description of each of our business segments.
Health Care
Products and Services
Health Care products consist of medical, pharmacy benefit management services, dental, behavioral health and vision plans offered on both an insured basis and an employer-funded, or administrative, basis and emerging businesses products and services, such as ACS, that complement and enhance our medical products. Medical products include point-of-service (“POS”), preferred provider organization (“PPO”), health maintenance organization (“HMO”) and indemnity benefit (“Indemnity”) plans. Medical products also include health savings accounts (“HSAs”) and Aetna HealthFund®, consumer-directed health plans that combine traditional POS or PPO and/or dental coverage, subject to a deductible, with an accumulating benefit account (which may be funded by the plan sponsor and/or the member in the case of HSAs). We also offer Medicare and Medicaid products and services and other medical products, such as medical management and data analytics services, medical stop loss insurance, workers' compensation administrative services and products that provide access to our provider networks in select geographies. We refer to insurance products (where we assume all or a majority of the risk for medical and dental care costs) as “Insured” and administrative services contract products (where the plan sponsor assumes all or a majority of the risk for medical and dental care costs) as “ASC.”
Our principal products and services are targeted specifically to large multi-site national, mid-sized and small employers. We also serve individual insureds, expatriates and, in certain markets, Medicare and Medicaid beneficiaries and providers. Medicare and Medicaid products and services are categorized separately from the Health Care products and services we sell to employers, other groups, individuals and providers, which we refer to as Commercial.
Our primary Commercial health care products are POS, PPO, HMO, HSA and Indemnity plans.
In addition to these primary Commercial health care products, in select geographies we also offer Medicare Advantage plans, Medicare Supplement plans and prescription drug coverage for Medicare beneficiaries and participate in Medicaid and subsidized State Children's Health Insurance Programs (“SCHIP”). SCHIP are state-subsidized insurance programs that provide benefits for families with uninsured children. We also have been selected to participate in Medicare-Medicaid demonstration projects in certain states which are scheduled to begin to operate in 2014. We are seeking to substantially grow our Medicare, Medicaid and Medicare-Medicaid demonstration project businesses over the next several years. Our Medicare and Medicaid products include:
Medicare
Through annual contracts with the Centers for Medicare & Medicaid Services (“CMS”), we offer HMO and PPO products for eligible individuals in certain geographic areas through the Medicare Advantage program. Members typically receive enhanced benefits over standard Medicare fee-for-service coverage, including reduced cost-sharing for preventive care, vision and other services. We offered network-based HMO and/or PPO plans in 634 counties in 40 states and Washington, D.C. in 2013, which includes our expanded Medicare presence as a result of the Coventry acquisition. In addition, we are expanding to 929 counties in 40 states and Washington, D.C. in 2014. As a result of changes in requirements that became effective in 2011, we ceased offering our remaining Medicare private fee-for-service (“PFFS”) products in 2011.
We are a national provider of the Medicare Part D Prescription Drug Program (“PDP”) in all 50 states and Washington, D.C. to both individuals and employer groups. All Medicare eligible individuals are eligible to participate in this voluntary prescription drug plan. Members typically receive coverage for certain prescription drugs, usually subject to a deductible, co-insurance and/or co-payment.
For certain qualifying employer groups, we offer our Medicare PPO products nationally. When combined with our PDP product, these national PPO plans form an integrated national fully-insured Medicare product for employers that provides medical and pharmacy benefits.
Medicare Supplement
For certain Medicare eligible members, we offer supplemental coverage for certain health care costs not covered by Medicare. The products included in our Medicare Supplement portfolio help to cover some of the gaps in Medicare, and include coverage for Medicare deductibles and coinsurance amounts.
We offered a wide selection of Medicare Supplement products in 44 states in 2013, including our products from the 2011 acquisition of Genworth's Medicare Supplement business and related blocks of in-force business.
Medicaid and SCHIP
We offer health care management services to individuals eligible for Medicaid and SCHIP under multi-year contracts which are subject to annual appropriations. We offered these services on an Insured or ASC basis in 15 states in 2013, which includes our expanded Medicaid presence as a result of the Coventry acquisition, which added approximately 919,000 Medicaid medical members on the Effective Date. We also offered targeted medical management services in one state in 2013, which terminated prior to December 31, 2013.
In addition to our the products described above, we also offer other products and services that primarily support our Commercial products, including:
Healthagen SM
Healthagen is a portfolio of growing businesses that tackles the fundamental needs of greater value, coordination and transparency in health care. The Healthagen portfolio includes a variety of HIT products and services, including our ACS, ActiveHealth and Medicity HIT solutions. These products and services are
marketed under the Healthagen brand name, and complement our Commercial, Medicare and Medicaid products.
Accountable Care Solutions
Our ACS products focus on growing membership in our medical products through provider collaborations that are designed to lower medical costs for us and our customers and make our products more affordable. Our ACS products offer a suite of solutions designed to facilitate delivery system reform and help reduce the cost of care by enabling population health management for providers. Our ACS products facilitate providers changing their business model from episodic acute care to patient population management which allows them to convert from volume-based reimbursement to value-based reimbursement. Our ACS products deploy Aetna's Medicity, Active Health and other capabilities to collaborate with providers in new ways to improve the quality and efficiency of care for all patients, whether they are Aetna members or members of other payors. In 2013, we began to expand our offering of HIT products and services to individuals in certain geographic areas who are eligible for Medicare Advantage and/or Medicaid programs. Our ACS products create mutually beneficial relationships with providers through a variety of methods, including alignment of financial incentives based on cost and quality, implementation of innovative HIT and deploying leading care management programs. In addition, at February 6, 2014, we had signed 32 ACO agreements and had collaborations under contract with Carilion Clinic, Heartland Health, Banner Health Network, Inova Health System, Memorial Hermann, among others.
ActiveHealth Management
Through the use of our patented CareEngine® system, our ActiveHealth Management products provide evidence-based medical management and data analytics products and services to a broad range of customers, including health plans, employers and others. ActiveHealth Management also is a key component of our ACS solutions.
Medicity
Medicity is a health information exchange company and a key component of our ACS solutions. Medicity offers a set of convenient, easy-to-access technology solutions for physicians, hospitals and other health care providers. These capabilities allow us to further the adoption of electronic health records and contribute to initiatives that foster administrative simplicity in health care, a key issue for consumers, patients and providers. Medicity offers us clinical data integration and secure data exchange capabilities. We acquired Medicity in 2011.
iTriage
The iTriage application gives smart phone and computer users access to a symptom navigator which assists users in finding nearby health facilities or physicians that could help with their specific health issue. iTriage assists users in finding health care that is right for them.
Personal Health Record
Our Personal Health Record provides members with online access to personal information, including personalized messages and alerts, detailed health history based on available claims data and voluntarily submitted information, and integrated information and resources to help members make informed decisions about their health care.
Behavioral Health
Our behavioral health and employee assistance products provide members who experience stress, depression and other types of mental health related illness with integrated behavioral health benefit administration, access to a network of providers and innovative wellness programs. We can provide customized behavioral health solutions to members in all 50 states.
Pharmacy
We offer pharmacy benefit management services and specialty and mail order pharmacy services to our members. Our pharmacy fulfillment services are delivered by Aetna Specialty Pharmacy (“ASP”) and Aetna Rx Home Delivery®. ASP compounds and dispenses specialty medications and offers certain support services associated with specialty medications. Specialty medications are generally injectable or infused medications that may not be readily available at local pharmacies. Aetna Rx Home Delivery® provides mail order prescription drug services. In 2011, CVS Caremark began to perform the administration of selected functions for our retail pharmacy network contracting and claims administration; mail order and specialty pharmacy order fulfillment and inventory purchasing and management; and certain administrative services for us. In addition, as a result of the Coventry acquisition, another supplier also provides certain pharmacy benefit management services to us and our customers.
Dental
We offer managed dental plans on an Insured and ASC basis. We are one of the nation's largest providers of dental coverage, based on membership at December 31, 2013.
Provider Network Access (“Cofinity”)
Through our Cofinity products, we provide access to regional health care provider networks to other insurance companies, third-party administrators, health plans and employers. Cofinity products predominantly are marketed in Michigan, Colorado and other states.
Stop Loss
We offer medical stop loss insurance coverage for certain employers who elect to self insure their health benefits. Under this product, we assume the costs associated with large individual claims and/or aggregate loss experience within an employer's plan above a pre-set annual threshold.
Aetna VisionSM Preferred
In January 2011, we began to offer vision benefits that provide members with access to one of the largest vision networks in the U.S. The Aetna Vision Preferred program can be customized with a wide range of benefit levels and co-payments. We are collaborating with EyeMed Vision Care LLC, a national vision benefits company, to offer this product to our customers.
Workers' Compensation Administrative Services
Our workers’ compensation administrative services products and services consist of fee-based, managed care services, such as provider network access, cost containment services, pharmacy benefit management, durable medical equipment and ancillary services, and care management services to underwriters and administrators of workers’ compensation insurance.
Other Commercial Products and Services
We offer a variety of other health care coverage products either as supplements to health products or as stand-alone products, such as indemnity programs, which may be offered on an Insured or an ASC basis. We also offer, directly or in cooperation with third parties, our Aetna Health ConnectionsSM disease management program which addresses over 35 chronic conditions, including heart failure, asthma and cancer.
In addition to Medicity, which is described on page 5, the acquisitions we completed in 2011 enhance the health care products and services we offer in the following manner:
Prodigy, and its flexible, highly customizable offerings enhanced our ASC products. Prodigy provides us with the capability to address affordability and quality for middle-sized and small businesses and customers who are primarily price-focused by offering third-party administrator (“TPA”) services for self-funded health care plans. Prodigy's established TPA services business extended our existing capabilities with an alternative product offering attractive to certain self-funded customers seeking a low fixed cost solution with additional service flexibility. It
also complements our ACS initiatives and enables a number of positive synergies, including using our provider networks and pharmacy benefit management services to enhance our ability to grow membership and develop customized networks in accountable care models.
Genworth's Medicare Supplement business and related blocks of in-force business substantially enhanced our presence, competitiveness, distribution and administrative capabilities as a provider of Medicare Supplement insurance. The acquisition significantly expanded our Medicare Supplement product offerings at a time when the Medicare population is anticipated to increase as “Baby Boomers” reach age 65.
Payflex strengthened our existing HSA administration offerings in our Commercial products by providing us with a next-generation platform for administering consumer-directed fund accounts. This acquisition enhanced our ability to provide members with flexible, customized, easy-to-use tools and solutions to better manage their health care expenses, which we believe are important given the increased focus on consumerism and the increasing amount of health care expenses paid by members.
We also offer comprehensive health care benefits and health management solutions worldwide through several different arrangements and offerings that include medical, dental, vision, life, disability and emergency assistance to expatriates, foreign nationals and other constituents. Our health management business collaborates with health care systems, government entities and plan sponsors around the world to design and build health management solutions to improve health, quality and cost outcomes. In November 2013, we entered into a definitive agreement to acquire the Interglobal group. Following completion, we expect this transaction to expand our footprint in fast growing geographies, increase our medical membership and enhance our international penetration with individuals and small and mid-sized business customers.
Provider Networks
We contract with physicians, hospitals and other providers for services to our customers. The health care providers who participate in our networks are independent contractors and are neither our employees nor our agents, except for providers who work in our mail-order and specialty pharmacy facilities.
We use a variety of techniques designed to help encourage appropriate utilization of medical services (“utilization”) and maintain affordability of quality coverage. In addition to contracts with health care providers for negotiated rates of reimbursement, these techniques include creating risk sharing arrangements that align economic incentives with our providers, the development and implementation of guidelines for the appropriate utilization of medical services and the provision of data to providers to enable them to improve health care quality.
At December 31, 2013, Aetna's underlying nationwide provider network had over 937,000 participating health care providers, including approximately 553,000 primary care and specialist physicians and approximately 5,500 hospitals. These figures do not reflect the inclusion of Coventry's provider networks, which have significantly increased the number of providers in our networks.
Accountable Care Solutions
We collaborate with hospitals and other providers through our ACS products. ACS arrangements focus on high value narrow network solutions to provide high-quality, low-cost options in local geographies. We are able to help enhance our relationships with hospitals and other providers through a variety of methods, including a re-alignment of financial incentives for providing high quality care, total cost management initiatives and risk sharing arrangements.
Primary Care Physicians
We compensate primary care physicians (“PCPs”) participating in our networks on both a fee-for-service and capitated basis, with capitation generally limited to HMO products in certain geographic areas and representing approximately five percent of health care costs in each of the last three years. In a fee-for-service arrangement, physicians are paid for health care services provided to the member based upon a set fee for the services provided. Under a capitation arrangement, physicians receive a monthly fixed fee for each member, regardless of the volume of health care services provided to the member. In some cases,
PCPs who are paid on a fee-for-service or capitated basis also receive additional incentive fees if certain performance metrics are attained.
Specialist Physicians
Specialist physicians participating in our networks are generally reimbursed at contracted rates per visit or per procedure.
Hospitals
We typically enter into contracts with hospitals that provide for per-day and/or per-case rates, often with fixed rates for ambulatory, surgery and emergency room services. We also have hospital contracts that provide for reimbursement based on a percentage of the charges billed by the hospital.
Our medical plans generally require notification of elective hospital admissions, and we monitor the length of hospital stays. Physicians who participate in our networks generally admit their patients in network-based products to participating hospitals using referral procedures that direct the hospital to contact our patient management unit in order to confirm the patient's membership status and facilitate the patient management process. This unit also assists members and providers with related activities, including, if necessary, the subsequent transition to the home environment and home care. Case management assistance for complex cases is provided by a special unit.
Other Providers
Laboratory, imaging, urgent care and other freestanding health facility providers are generally paid under fee-for-service arrangements, except for certain laboratory services.
Quality Assessment
CMS uses a 5-star rating system to monitor plans and ensure that they meet CMS's quality standards. CMS uses this rating system to provide Medicare beneficiaries with a tool that they can use to compare the overall quality of care and level of customer service of companies that provide Medicare health care and drug plans. The rating system considers a variety of measures, including quality of preventative services, chronic illness management and overall customer satisfaction.
We seek Health Plan accreditation for our HMO plans from the National Committee for Quality Assurance (the “NCQA”), a national organization established to review the quality and medical management systems of health care plans. Health care plans seeking accreditation must pass a rigorous, comprehensive review and must annually report on their performance.
Aetna Life Insurance Company (“ALIC”), a wholly-owned subsidiary of Aetna, has received nationwide NCQA PPO Health Plan accreditation, through January 24, 2017. At December 31, 2013, all of our eligible Commercial HMO and PPO members participated in HMOs or PPOs that received accreditation by the NCQA.
We also seek accreditation and certification for other products from NCQA and URAC (formally known as American Accreditation HealthCare Commission, Inc.), another national organization founded to establish standards for the health care industry. Purchasers and consumers look to URAC's and NCQA's accreditation and certification as an indication that a health care organization has the necessary structures and processes to promote high-quality care and preserve patient rights. In addition, regulators in over 80% of the states recognize NCQA's accreditation and certification standards.
Our provider selection and credentialing/recredentialing policies and procedures are consistent with NCQA and URAC, as well as state and federal, requirements. In addition, we are certified under the NCQA Credentials Verification Organization (“CVO”) certification program for all certification options through January 29, 2015. Our URAC CVO accreditation is valid through October 1, 2015.
Our quality assessment programs for contracted providers who participate in our networks begin with the initial review of health care practitioners. Practitioners' licenses and education are verified, and their work history is
collected by us or in some cases by the practitioner's affiliated group or organization. We generally require participating hospitals to be certified by CMS or accredited by the Joint Commission, the American Osteopathic Association, or Det Norske Veritas Healthcare.
We also offer quality and outcome measurement programs, quality improvement programs, and health care data analysis systems to providers and purchasers of health care services.
Principal Markets and Sales
Our medical membership is dispersed throughout the U.S., and we serve a limited but growing number of members in certain countries outside the U.S. Refer to Note 19 of Notes to Consolidated Financial Statements, beginning on page 135 of the Annual Report, which is incorporated herein by reference, for additional information on our foreign customers. We offer a broad range of traditional, voluntary and consumer-directed health insurance products and related services, many of which are available nationwide. Depending on the product, we market to a range of customers including employer groups, individuals, college students, part-time and hourly workers, health plans, providers, governmental units, government-sponsored plans, labor groups and expatriates.
The following table presents total medical membership by U.S. and other geographic region and funding arrangement at December 31, 2013, 2012 and 2011:
(Thousands)
Insured
ASC
Total
Insured
ASC
Total
Insured
ASC
Total
Northeast
2,267
2,814
5,081
1,787
2,662
4,449
1,847
2,628
4,475
Southeast
1,906
3,013
4,919
1,150
2,803
3,953
1,119
2,854
3,973
Mid-America
2,071
2,795
4,866
2,251
3,124
2,226
3,023
West
2,010
4,088
6,098
1,633
3,986
5,619
1,715
4,267
5,982
Other
1,226
1,097
1,006
Total medical membership
8,615
13,575
22,190
5,758
12,484
18,242
5,755
12,704
18,459
Additional information on Health Care's membership is included in the “Membership” section of the MD&A, on page 11 of the Annual Report, which is incorporated herein by reference.
We market both Insured and ASC products and services primarily to employers that sponsor our products (also called “plan sponsors”) for the benefit of their employees and their employees' dependents. Frequently, larger employers offer employees a choice among coverage options, from which the employee makes his or her selection during a designated annual open enrollment period. Typically, employers pay all of the monthly premiums to us and, through payroll deductions, obtain reimbursement from employees for a percentage of the premiums that is determined by each employer. Some Health Care products are sold directly to employees of employer groups on a fully employee-funded basis. In some cases, we bill the covered individual directly. We also sell Insured plans directly to individual consumers in a number of states.
We offer Insured Medicare coverage on an individual basis as well as through employer groups to their retirees. Medicaid and SCHIP members are enrolled on an individual basis.
Health Care products are sold through our sales personnel, as well as through independent brokers, agents and consultants who assist in the production and servicing of business; Public Exchanges; and Private Exchanges. For large plan sponsors, independent consultants and brokers are frequently involved in employer health plan selection decisions and sales. In some instances, we may pay commissions, fees and other amounts to brokers, agents, consultants and sales representatives who place business with us. In certain cases, our customer pays the broker for services rendered, and we may facilitate that arrangement by collecting the funds from the customer and transmitting them to the broker. We support our marketing and sales efforts with an advertising program that may include television, radio, billboards, print media and social media, supplemented by market research and direct marketing efforts.
Pricing
For Commercial Insured plans, employer group contracts containing the pricing and other terms of the relationship are generally established in advance of the policy period and typically have a duration of one year. Fees under our ASC plans are generally fixed for a period of one year.
We use prospective rating methodologies in determining the premium rates charged to the majority of employer groups, and we also use retrospective rating methodologies for a limited number of groups. Premium rates for customers with more than approximately 125 employees generally take into consideration the individual plan sponsor's historical and anticipated claim experience where permitted by law. Some states may prohibit the use of one or more of these rating methods for some customers, such as small employer groups, or all customers.
Under prospective rating, a fixed premium rate is determined at the beginning of the policy period. We typically cannot recover unanticipated increases in health care costs in the current policy period; however, we may consider prior experience for a product in the aggregate or for a specific customer, among other factors, in determining premium rates for future policy periods. Where required by state laws, premium rates are filed and approved by state regulators prior to contract inception. Our future results could be adversely affected if the premium rates we request are not approved or are adjusted downward or their approval is delayed by state or federal regulators.
Under retrospective rating, we determine a premium rate at the beginning of the policy period. After the policy period has ended, the actual claim and cost experience is reviewed. If the actual claim costs and other expenses are less than expected, we may issue a refund to the plan sponsor based on this favorable experience. If the experience is unfavorable, in certain instances we may recover the resulting deficit through contractual provisions or consider the deficit in setting future premium levels. However, we may not recover the deficit if a plan sponsor elects to terminate coverage. Retrospective rating may be used for Commercial Insured plans that cover more than approximately 300 lives.
We have Medicare Advantage and PDP contracts with CMS to provide HMO, PPO and prescription drug coverage to Medicare beneficiaries in certain geographic areas. Under these annual contracts, CMS pays us a fixed capitation payment and/or a portion of the premium, both of which are based on membership and adjusted for demographic and health risk factors. CMS also considers inflation, changes in utilization patterns and average per capita fee-for-service Medicare costs in the calculation of the fixed capitation payment or premium. Our PDP contracts also provide a risk-sharing arrangement with CMS to limit our exposure to unfavorable expenses or benefit from favorable expenses. Amounts payable to us under the Medicare arrangements are subject to annual revision by CMS, and we elect to participate in each Medicare service area or region on an annual basis. Premiums paid to us for Medicare products are subject to federal government reviews and audits, which can result, and have resulted, in retroactive and prospective premium adjustments. In addition to payments received from CMS, most of our Medicare Advantage products and all of our PDP products require a supplemental premium to be paid by the member or sponsoring employer. In some cases these supplemental premiums are adjusted based on the member's income and asset levels. Compared to Commercial products, Medicare contracts generate higher per member per month revenues and health care costs.
Beginning in 2012, Health Care Reform ties a portion of each Medicare Advantage plan's reimbursement to the plan's “star ratings.” In 2013 and 2014, those plans that received a rating of three or more stars are eligible for quality-based bonus payments. Beginning in 2015, plans must have a star rating of four or higher to qualify for bonus payments. Our average star rating increased from 3.53 in 2013 to 4.04 in 2014, and for 2014 97% of our Medicare Advantage members are in plans rated at least 3.5 stars and 62% of our Medicare Advantage members are in plans rated at least 4.0 stars. CMS released updated star ratings in October 2013 that were used to determine the portion of our Medicare Advantage membership that will reside in plans with ratings of four stars or higher and qualify for bonus payments in 2015. Our Medicare Advantage plans' operating results from 2012 forward are likely to continue to be significantly determined by their star ratings.
Rates for our Medicare Supplement products are regulated at the state level and vary by state.
Under our Insured Medicaid contracts, state government agencies pay us fixed monthly rates per member that vary by state, line of business and demographics; and we arrange, pay for and manage health care services provided to Medicaid beneficiaries. These rates are subject to change by each state, and in some instances, provide for adjustment for health risk factors. CMS requires these rates to be actuarially sound. We also receive fees from our customers where we provide services under ASC Medicaid contracts. Our ASC Medicaid contracts generally are for periods of more than one year, and certain of them contain performance incentives and limited financial risk sharing with respect to certain medical, financial and operational metrics. Under these arrangements, performance is evaluated annually, with associated financial incentive opportunities and our financial risk share obligations typically limited to a percentage of the fees otherwise payable to us. Payments to us under our Medicaid contracts are subject to the annual appropriation process in the applicable state.
We offer HMO and consumer-directed medical and dental plans to federal employees under the Federal Employees Health Benefits Program and the Federal Employees Dental and Vision Insurance Program. Premium rates and fees for those plans are subject to federal government review and audit, which can result, and have resulted, in retroactive and prospective premium and fee adjustments.
Starting in 2014, Health Care Reform imposes significant new industry-wide fees, assessments and taxes. In 2013, Aetna included a portion of these Health Care Reform fees, assessments and taxes in the pricing for our 2013 contract renewals with members months in 2014. Our goal is to collect in premiums and fees or solve for all of these estimated fees, assessments and taxes.
Competition
The health care benefits industry is highly competitive, primarily due to a large number of for-profit and not-for-profit competitors, our competitors' marketing and pricing, and a proliferation of competing products, including new products that are continually being introduced into the market. New entrants into the marketplace, as well as significant consolidation within the industry, have contributed to the competitive environment. In addition, the rapid pace of change as the industry evolves towards a consumer-focused retail marketplace, including Public and Private Exchanges, and the increased use of technology to interact with members, providers and customers, increase the risks we currently face from new entrants and disruptive actions by existing competitors compared to prior periods.
We believe that the significant factors that distinguish competing health plans include the perceived overall quality (including accreditation status), quality of service, comprehensiveness of coverage, cost (including premium rates, provider discounts and member out-of-pocket costs), product design, financial stability and ratings, breadth and quality of provider networks, ability to offer different provider network options, providers available in such networks, and quality of member support and care management programs. We believe that we are competitive on each of these factors. Our ability to increase the number of persons covered by our plans or to increase our revenues is affected by our ability to differentiate ourselves from our competitors on these factors. Competition may also affect the availability of services from health care providers, including primary care physicians, specialists and hospitals.
Our Insured products compete with local and regional health care benefits plans, in addition to health care benefits and other plans sponsored by other large commercial health care benefit insurance companies and numerous for-profit and not-for-profit organizations operating under licenses from the Blue Cross and Blue Shield Association. Additional competitors include other types of medical and dental provider organizations, various specialty service providers (including pharmacy benefit management services providers), integrated health care delivery organizations, HIT companies and, for certain plans, programs sponsored by the federal or state governments. Our ability to increase the number of persons enrolled in our Insured products also is affected by the desire and ability of employers to self-fund their health coverage.
Our ASC plans compete primarily with other large commercial health care benefit companies, numerous for-profit and not-for-profit organizations operating under licenses from the Blue Cross and Blue Shield Association and third-party administrators.
Our international products compete with local, global and U.S.-based health plans and commercial health care benefit insurance companies, many of whom have a longer operating history and better brand recognition and greater market place presence in one or more geographies.
The provider solutions and HIT marketplaces and provider solutions and HIT products are evolving rapidly. We compete for provider solutions and HIT business with other large health plans and commercial health care benefit insurance companies as well as information technology companies and companies that specialize in provider solutions and HIT. Many of our information technology product competitors have longer operating histories, better brand recognition, greater market place presence and more experience in developing innovative products.
In addition to competitive pressures affecting our ability to obtain new customers or retain existing customers, our membership has been and may continue to be adversely affected by uncertain economic conditions and reductions in workforce by existing customers due to adverse and uncertain general economic conditions, especially in the U.S. and industries where our membership is concentrated.
Reinsurance
We currently have several reinsurance agreements with nonaffiliated insurers that relate to Health Care insurance policies. We entered into these contracts to reduce the risk of catastrophic losses which in turn reduces our capital and surplus requirements. We frequently evaluate reinsurance opportunities and refine our reinsurance and risk management strategies on a regular basis.
Factors Affecting Forward-Looking Information
Information regarding certain of the important factors that may materially affect our Health Care business and our statements concerning future events is included in the “Forward-Looking Information/Risk Factors” section of the MD&A, beginning on page 46 of the Annual Report, which is incorporated herein by reference.
Group Insurance
Principal Products
Group Insurance products consist primarily of the following:
•
Life Insurance Products consist principally of group term life insurance, the amounts of which may be fixed or linked to individual employee wage levels. We also offer voluntary spouse and dependent term life insurance, and group universal life and accidental death and dismemberment insurance. We offer life insurance products on an Insured basis.
•
Disability Insurance Products provide employee income replacement benefits for both short-term and long-term disability. We also offer disability products with additional case management features. Similar to Health Care products, we offer disability benefits on both an Insured and employer-funded basis. We also provide absence management services to employers, including short-term and long-term disability administration and leave management.
•
Long-Term Care Insurance Products provide benefits to cover the cost of care in private home settings, adult day care, assisted living or nursing facilities. Long-term care benefits were offered primarily on an Insured basis. The product was available on both a service reimbursement and disability basis. We no longer solicit or accept new long-term care customers.
Principal Markets and Sales
We offer our Group Insurance products in 49 states as well as Washington, D.C., Puerto Rico, the U.S. Virgin Islands and Canada. Depending on the product, we market to a range of customers from small employer groups to large, multi-site and/or multi-state employer programs.
We market Group Insurance products and services primarily to employers that sponsor our products for the benefit of their employees and their employees' dependents. Frequently, employers offer employees a choice of benefits, from which the employee makes his or her selection during a designated annual open enrollment period. Typically, employers pay all of the monthly premiums to us and, through payroll deductions, obtain reimbursement from employees for a percentage of the premiums that is determined by each employer. Some Group Insurance products are sold directly to employees of employer groups on a fully employee-funded basis. In some cases, we bill the covered individual directly.
Group Insurance products are sold through our sales personnel, as well as through independent brokers, agents and consultants who assist in the production and servicing of business. For large plan sponsors, independent consultants and brokers are frequently involved in employer plan selection decisions and sales. We pay commissions, fees and other amounts to brokers, agents, consultants and sales representatives who place business with us. We support our marketing and sales efforts with an advertising program that may include direct marketing efforts as well as television, radio, billboards, print media and social media, supplemented by market research.
Pricing
For Insured Group Insurance plans, employer group contracts containing the pricing and other terms of the relationship are generally established in advance of the policy period. We use prospective and retrospective rating methodologies to determine the premium rates charged to employer groups. These are typically offered with rate guarantees that generally range from one to three years.
Under prospective rating, a fixed premium rate is determined at the beginning of the policy period. We cannot recover unanticipated increases in mortality or morbidity costs in the current policy period; however, we may consider prior experience for a product in the aggregate or for a specific customer, among other factors, in determining premium rates for future policy periods.
Under retrospective rating, we determine a premium rate at the beginning of the policy period. After the policy period has ended, the actual claim and cost experience is reviewed. If the actual claim costs and other expenses are less than expected, we may issue a refund to the plan sponsor based on this favorable experience. If the experience is unfavorable, we consider the deficit in setting future premium levels, and in certain instances, we may recover the deficit through contractual provisions such as offsets against refund credits that develop for future policy periods. However, we may not recover the deficit if a plan sponsor elects to terminate coverage. Retrospective rating is most often used for Insured employer-funded plans that cover more than approximately 3,000 lives.
Competition
For the group insurance industry, we believe that the significant factors that distinguish competing companies are cost, quality of service, financial strength of the insurer, comprehensiveness of coverage, and product array and design. We believe we are reasonably competitive on each of these factors; however, many of our competitors have greater scale, financial and other resources, financial strength and brand recognition and lower expenses. The group life and group disability markets remain highly competitive.
Reinsurance
We currently have several reinsurance agreements with nonaffiliated insurers that relate to both life and long-term disability products. Most reinsurance arrangements are established on a case-by-case basis, and a subset of our reinsurance agreements cover closed blocks of business and cancelled cases. We also have reinsurance that provides a limited degree of catastrophic risk protection for certain of our life products. We frequently evaluate reinsurance opportunities and refine our reinsurance and risk management strategies on a regular basis.
Factors Affecting Forward-Looking Information
Information regarding certain of the important factors that may materially affect our Group Insurance business and our statements concerning future events is included in the “Forward-Looking Information/Risk Factors” section of the MD&A, beginning on page 46 of the Annual Report, which is incorporated herein by reference.
Large Case Pensions
Principal Products
Large Case Pensions manages a variety of retirement products (including pension and annuity products) primarily for tax-qualified pension plans. We do not actively market Large Case Pensions products, but continue to accept deposits from existing customers and manage the run-off of our existing business. Contracts provide non-guaranteed, experience-rated and guaranteed investment options through general and separate account products. Large Case Pensions products that use separate accounts provide contract holders with a vehicle for investments under which the contract holders primarily assume the investment risk. Large Case Pensions earns a management fee on these separate accounts.
In 1993, we discontinued our fully-guaranteed Large Case Pensions products. Information regarding these products is incorporated herein by reference to Note 20 of Notes to Consolidated Financial Statements beginning on page 137 in the Annual Report.
Factors Affecting Forward-Looking Information
Information regarding certain of the important factors that may materially affect our Large Case Pensions business and our statements concerning future events is included in the “Forward-Looking Information/Risk Factors” section of the MD&A, beginning on page 46 of the Annual Report, which is incorporated herein by reference.
Other Matters
Access to Reports
Our reports to the U.S. Securities and Exchange Commission (the “SEC”), including our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and any amendments to those reports are available without charge on our website at www.aetna.com as soon as practicable after they are electronically filed with or furnished to the SEC. The information on or linked to our website is neither a part of nor incorporated by reference in this Form 10-K or any of our other SEC filings. Copies of these reports are also available, without charge, from Aetna's Investor Relations Department, 151 Farmington Avenue, Hartford, CT 06156.
Regulation
For information regarding significant regulation affecting us, refer to “Regulatory Environment” and for a discussion of certain factors that may cause our actual results to differ from currently anticipated results in connection with regulation that affects us, see “Forward-Looking Information/Risk Factors”, each sections of the MD&A, beginning on pages 29 and 46, respectively, of the Annual Report, which are incorporated herein by reference.
Patents and Trademarks
We own a number of trademarks and patents that are important to Aetna. Some of the trademarks include Aetna®, as well as the corresponding Aetna design logo, Aetna Navigator®, ActiveHealth®, CareEngine®, CarePass®, Coventry®, DocFind®, HealthagenSM, Healthy Merits®, Involve CareSM, iTriage®, Medicity®, Meritain Health®, NeoCare SolutionsSM, PayFlex®, Practice IQSM, Prodigy Health Group® and WellmatchSM. Some of our patents include the CareEngine patent that expires in 2021, the iNexx architecture patent that expires in 2025, and the Master Patient Index patent that expires in 2028. We consider these patents and trademarks and our other patents, trademarks and trade names important in the operation of our business. However, our business, including that of each of our individual segments, is not dependent on any individual patent, trademark or trade name.
Employees
We had approximately 48,600 employees at December 31, 2013.
Customer Concentration
The U.S. federal government is a significant customer of both the Health Care segment and the Company. Premiums and fees and other revenue paid by the federal government accounted for approximately 28% of the Health Care segment's revenue and 26% of our consolidated revenue in 2013. Contracts with CMS for coverage of Medicare-eligible individuals accounted for 87% of our federal government premiums and fees and other revenue, with the balance coming from federal employee-related benefit programs. No other individual customer, in any of our segments, accounted for 10% or more of our consolidated revenues in 2013. Our segments are not dependent upon a single customer or a few customers, the loss of which would have a significant effect on the earnings of a segment. The loss of business from any one, or a few, independent brokers or agents would not have a material adverse effect on our earnings or the earnings of any of our segments. Refer to Note 19 of Notes to Consolidated Financial Statements, beginning on page 135 of the Annual Report, which is incorporated herein by reference, regarding segment information.
Item 1A. Risk Factors
The information contained in the “Forward-Looking Information/Risk Factors” section of the MD&A, which begins on page 46 of the Annual Report, is incorporated herein by reference.
Item 1B. Unresolved Staff Comments
None.
Item 2. Properties
Our principal office is a building complex that is approximately 1.7 million square feet in size and is located at 151 Farmington Avenue, Hartford, Connecticut. Our principal office is used by all of our business segments. We also own or lease other space in the greater Hartford area, Bethesda, Maryland, Blue Bell, Pennsylvania, and various field locations in the U.S. and several foreign countries. Such properties are primarily used by our Health Care segment. We believe our properties are adequate and suitable for our business as presently conducted.
Item 3. Legal Proceedings
The information contained under “Litigation and Regulatory Proceedings” in Note 18 of Notes to Consolidated Financial Statements, which begins on page 130 of the Annual Report, is incorporated herein by reference.
Item 4. Mine Safety Disclosures
Not applicable.
EXECUTIVE OFFICERS OF THE REGISTRANT
Aetna's Chairman is elected by Aetna's Board of Directors (our “Board”). All of Aetna's other executive officers listed below are appointed by our Board, generally at its Annual Meeting, and such persons hold office until the next Annual Meeting of our Board or until their successors are elected or appointed. None of these officers has a family relationship with any other executive officer or Director. In addition, there are no arrangements or understandings, other than those with Directors or executive officers acting solely in their capacities as such, pursuant to which these executive officers were appointed.
Name of Executive Officer
Position*
Age *
Mark T. Bertolini
Chairman, Chief Executive Officer and President
Joseph M. Zubretsky
Senior Executive Vice President, National Businesses
Karen S. Rohan
Executive Vice President, Local and Regional Businesses
Francis S. Soistman
Executive Vice President, Government Services
Margaret M. McCarthy
Executive Vice President, Operations and Technology
Shawn M. Guertin
Executive Vice President, Chief Financial Officer and Chief Enterprise Risk Officer
William J. Casazza
Executive Vice President and General Counsel
Lonny Reisman, M.D.
Executive Vice President and Chief Medical Officer
*As of February 28, 2014
Executive Officers' Business Experience During Past Five Years
Mark T. Bertolini serves as Aetna's Chairman, having held that position since April 8, 2011. Mr. Bertolini was elected to Aetna's Board and has served as Chief Executive Officer since November 29, 2010. Mr. Bertolini also serves as President, having held that position since July 24, 2007.
Joseph M. Zubretsky became Senior Executive Vice President, National Businesses in February 2013, having served as Senior Executive Vice President from November 29, 2010 and as Executive Vice President from February 28, 2007. Mr. Zubretsky also served as Chief Financial Officer from February 28, 2007 to February 25, 2013 and Chief Enterprise Risk Officer from April 27, 2007 to February 25, 2013.
Karen S. Rohan became Executive Vice President, Local and Regional Businesses in February 2013, having served as Executive Vice President, Head of Specialty Products since July 23, 2012. Prior to joining Aetna, Ms. Rohan served as President of Magellan Health Services, a position she assumed in August 2009. Prior to that, Ms. Rohan served as President, CIGNA Group Insurance, Dental and Vision, a position she assumed in November 2005.
Francis S. Soistman became Executive Vice President, Government Services on June 14, 2013, having served as Vice President, Medicare since May 20, 2013 and Head of Medicare since January 14, 2013. Prior to joining Aetna, Mr. Soistman served as Executive Vice President of Jessamine Healthcare, a position he assumed in 2010. Prior to that, Mr. Soistman served as Executive Vice President, Individual Consumer and Government Business Division at Coventry.
Margaret M. McCarthy became Executive Vice President, Operations and Technology on November 29, 2010, having served as Chief Information Officer and Senior Vice President Innovation, Technology and Service Operations since January 1, 2010. Ms. McCarthy also served as Chief Information Officer and Senior Vice President of Procurement and Real Estate from January 30, 2008 to December 31, 2009.
Shawn M. Guertin became Executive Vice President, Chief Financial Officer and Chief Enterprise Risk Officer on January 2, 2014, having served as Senior Vice President, Chief Financial Officer and Chief Enterprise Risk Officer since February 25, 2013. Prior to that, Mr. Guertin served as the Head of Business Segment Finance since April 2011. Prior to joining Aetna, Mr. Guertin had served as a consultant to Coventry from January 1, 2010 to December 31, 2010, and as Executive Vice President, Chief Financial Officer and Treasurer of Coventry from March 2005 through November 2009.
William J. Casazza became Executive Vice President and General Counsel on January 2, 2014, having served as Senior Vice President and General Counsel since September 6, 2005.
Lonny Reisman, M.D., became Executive Vice President and Chief Medical Officer on January 2, 2014, having served as Senior Vice President and Chief Medical Officer since November 12, 2008. Prior to that, Dr. Reisman served as Chief Executive Officer and a director of ActiveHealth Management, Inc. since October 1998. Dr. Reisman is expected to leave Aetna in April 2014.
Part II
Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Our common shares (“common stock”) are listed on the New York Stock Exchange, where they trade under the symbol AET. As of January 31, 2014, there were 7,614 record holders of our common stock.
Our Board authorized six separate share repurchase programs on May 20, 2011, September 23, 2011, February 24, 2012, July 27, 2012, February 19, 2013 and September 27, 2013, respectively. Each repurchase program authorized us to repurchase up to $750 million of our common stock. On February 28, 2014, our Board authorized a new share repurchase program that authorized us to repurchase up to $1.0 billion of our common stock. During the three months ended December 31, 2013, we repurchased approximately 7 million shares of our common stock at a cost of approximately $450 million under the September 27, 2013 and February 19, 2013 programs. At December 31, 2013, we had remaining authorization to repurchase approximately $597 million of common stock under the September 27, 2013 authorization.
The following table provides information about our monthly share repurchases, all of which were purchased as part of a publicly-announced program, for the three months ended December 31, 2013:
Issuer Purchases of Equity Securities
(Millions, except per share amounts)
Total Number
of Shares
Purchased
Average Price Paid per Share
Total Number of
Shares Purchased
as Part of Publicly
Announced
Plans or Programs
Approximate Dollar
Value of Shares
that May Yet Be
Purchased Under the
Plans or Programs
October 1, 2013 - October 31, 2013
.2
$
62.70
.2
$
1,035.4
November 1, 2013 - November 30, 2013
3.5
65.08
3.5
803.4
December 1, 2013 - December 31, 2013
3.1
66.66
3.1
597.0
Total
6.8
$
65.73
6.8
N/A
Prior to February 2011, our policy had been to pay an annual dividend of $.04 per share. In February 2011, we announced that our Board increased our cash dividend to shareholders to $.15 per share and moved us to a quarterly dividend payment cycle. On December 2, 2011, our Board increased our quarterly cash dividend to shareholders to $.175 per common share. On November 30, 2012, our Board increased our quarterly dividend to shareholders to $.20 per common share. On December 6, 2013, our Board increased our quarterly dividend to shareholders to $.225 per common share. On February 28, 2014, our Board declared a cash dividend of $.225 per common share that will be paid on April 25, 2014, to shareholders of record at the close of business on April 10, 2014. Declaration and payment of future dividends is at the discretion of our Board and may be adjusted as business needs or market conditions change. Information regarding restrictions on our present and future ability to pay dividends is included
in the “Liquidity and Capital Resources” section of the MD&A and Note 16 of Notes to Consolidated Financial Statements, beginning on pages 18 and 129, respectively, of the Annual Report, which are incorporated herein by reference. Information regarding quarterly common stock prices is incorporated herein by reference to the “Quarterly Data (unaudited)” included on page 143 of the Annual Report.
Item 6. Selected Financial Data
The information contained in “Selected Financial Data” on page 76 of the Annual Report is incorporated herein by reference.
Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations
The information contained in the MD&A, beginning on page 2 of the Annual Report, is incorporated herein by reference.
Item 7A. Quantitative and Qualitative Disclosures About Market Risk
The information contained in the “Risk Management and Market-Sensitive Instruments” section of the MD&A, beginning on page 17 of the Annual Report, is incorporated herein by reference.
Item 8. Financial Statements and Supplementary Data
The information contained in Consolidated Financial Statements, Notes to Consolidated Financial Statements, Report of Independent Registered Public Accounting Firm and “Quarterly Data (unaudited),” beginning on page 77 of the Annual Report, is incorporated herein by reference.
Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure
None.
Item 9A. Controls and Procedures
Disclosure Controls and Procedures
We maintain disclosure controls and procedures, which are designed to ensure that information that we are required to disclose in the reports we file or furnish under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.
An evaluation of the effectiveness of our disclosure controls and procedures as of December 31, 2013 was conducted under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures as of December 31, 2013 were designed to ensure that material information relating to Aetna Inc. and its consolidated subsidiaries would be made known to the Chief Executive Officer and Chief Financial Officer by others within those entities, particularly during the periods when periodic reports under the Exchange Act are being prepared and were effective. Refer to the Certifications by our Chief Executive Officer and Chief Financial Officer filed as Exhibits 31.1 and 31.2 to this Form 10-K.
Management's Report on Internal Control Over Financial Reporting
Management's Report on Internal Control Over Financial Reporting, on page 141 of the Annual Report, is incorporated herein by reference.
Report of Independent Registered Public Accounting Firm
The Report of Independent Registered Public Accounting Firm, on page 142 of the Annual Report, is incorporated herein by reference.
Changes in Internal Control over Financial Reporting
There has been no change in our internal control over financial reporting identified in connection with the evaluation of such control that occurred during our fourth fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
Item 9B. Other Information
None.
Part III
Item 10. Directors, Executive Officers and Corporate Governance
Information concerning the Executive Officers of Aetna Inc. is included in Part I pursuant to General Instruction G to Form 10-K.
Information concerning our Directors, our Directors' and certain of our executives' compliance with Section 16(a) of the Exchange Act, our Code of Conduct (our written code of ethics) and our audit committee and audit committee financial experts is incorporated herein by reference to the information under the captions “Nominees for Directorships,” “Section 16(a) Beneficial Ownership Reporting Compliance,” “Aetna's Code of Conduct” and “Board and Committee Membership; Committee Descriptions” in the Proxy Statement.
Item 11. Executive Compensation
The information under the captions “Compensation Discussion and Analysis,” “Director Compensation Philosophy and Elements,” “2013 Nonmanagement Director Compensation,” “Additional Director Compensation Information,” “Executive Compensation,” “Compensation Committee Interlocks and Insider Participation” and “Compensation Committee Report” in the Proxy Statement is incorporated herein by reference.
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
The information under the caption “Security Ownership of Certain Beneficial Owners, Directors, Nominees and Executive Officers” and “Equity Compensation Plans” in the Proxy Statement is incorporated herein by reference.
Item 13. Certain Relationships and Related Transactions, and Director Independence
The information under the captions “Director Independence” and “Related Party Transaction Policy” in the Proxy Statement is incorporated herein by reference.
Item 14. Principal Accounting Fees and Services
The information under the captions “Fees Incurred for 2013 and 2012 Services Performed by the Independent Registered Public Accounting Firm” and “Nonaudit Services and Other Relationships Between the Company and the Independent Registered Public Accounting Firm” in the Proxy Statement is incorporated herein by reference.
Part IV
Item 15. Exhibits, Financial Statement Schedules
The following documents are filed as part of this Form 10-K:
Financial Statements
The Consolidated Financial Statements, Notes to Consolidated Financial Statements and Report of Independent Registered Public Accounting Firm, which begin on pages 77, 82 and 142, respectively, of the Annual Report, are incorporated herein by reference.
Financial statement schedule
The “Condensed Financial Information of Aetna Inc. (Parent Company Only)” is included in this Item 15. Refer to Index to Financial Statement Schedule on page 26.
Exhibits*
Exhibits to this Form 10-K are as follows:
Articles of Incorporation and By-Laws
3.1
Amended and Restated Articles of Incorporation of Aetna Inc., incorporated herein by reference to Exhibit 99.1 to Aetna Inc.'s Form 8-K filed on May 2, 2007 (SEC file number 001-16095).
3.2
Amended and Restated By-Laws of Aetna Inc., incorporated herein by reference to Exhibit 3.1 to Aetna Inc.'s Form 8-K filed on February 28, 2012.
Instruments defining the rights of security holders, including indentures
4.1
Form of Aetna Inc. Common Share certificate, incorporated herein by reference to Exhibit 4.1 to Aetna Inc.'s Amendment No. 2 to Registration Statement on Form 10 filed on December 1, 2000.
4.2
Senior Indenture dated as of March 2, 2001, between Aetna Inc. and U.S. Bank National Association, successor in interest to State Street Bank and Trust Company, incorporated herein by reference to Exhibit 4.2 to Aetna Inc.'s Registration Statement on Form S-3 filed on December 2, 2011.
4.3
Form of Subordinated Indenture between Aetna Inc. and U.S. Bank National Association, incorporated herein by reference to Exhibit 4.3 to Aetna Inc.'s Registration Statement on Form S-3 filed on December 2, 2011.
4.4
Supplemental Indenture dated as of May 20, 2011 between Aetna Inc. and U.S. Bank National Association, as successor-in-interest to State Street Bank and Trust Company, as trustee, establishing and designating Aetna Inc.'s 4.125% Senior Notes due June 1, 2021, incorporated herein by reference to Exhibit 4.1 to Aetna Inc.'s Form 8-K filed on May 20, 2011.
4.5
Supplemental Indenture dated as of May 4, 2012 between Aetna Inc. and U.S. Bank National Association, as successor-in-interest to State Street Bank and Trust Company, as trustee, establishing and designating Aetna Inc.'s 1.750% Senior Notes due May 15, 2017 and 4.500% Senior Notes due May 15, 2042, incorporated herein by reference to Exhibit 4.1 to Aetna Inc.'s Form 8-K filed on May 4, 2012.
4.6
Supplemental Indenture dated as of November 7, 2012 between Aetna Inc. and U.S. Bank National Association, as successor-in-interest to State Street Bank and Trust Company, as trustee, establishing and designating Aetna Inc.'s 1.500% Senior Notes due November 15, 2017, 2.750% Senior Notes due November 15, 2022 and 4.125% Senior Notes due November 15, 2042, incorporated herein by reference to Exhibit 4.1 to Aetna Inc.'s Form 8-K filed on November 7, 2012.
4.7
Indenture, dated as of January 28, 2005, between Coventry Health Care, Inc., as Issuer, and U.S. Bank National Association, as successor to Wachovia Bank, National Association, as Trustee (incorporated by reference to Exhibit 4.2 to Coventry Health Care, Inc.’s Current Report on Form 8-K filed on January 28, 2005 (SEC file number 001-16477)), incorporated herein by reference to Exhibit 4.1 to Aetna Inc.'s Form 10-Q filed on July 30, 2013.
4.8
First Supplemental Indenture, dated as of May 7, 2013, among Aetna Inc., as Guarantor, Coventry Health Care, Inc., as Issuer, and U.S. Bank National Association, as Trustee, incorporated herein by reference to Exhibit 4.3 to Aetna Inc.'s Form 10-Q filed on July 30, 2013.
4.9
Form of Note for the 2015 Notes issued pursuant to the Indenture, dated as of January 28, 2005, between Coventry Health Care, Inc. and Wachovia Bank, National Association, as Trustee (included as Exhibit A to the Indenture) (incorporated by reference to Exhibit 4.2 to Coventry Health Care, Inc.'s Current Report on Form 8-K filed on January 28, 2005 (SEC file number 001-16477)), incorporated herein by reference to Exhibit 4.2 to Aetna Inc.'s Form 10-Q filed July 30, 2013.
4.10
Indenture, dated as of March 20, 2007, between Coventry Health Care, Inc., as Issuer, and The Bank of New York, as Trustee (incorporated by reference to Exhibit 4.1 to Coventry Health Care, Inc.'s Current Report on Form 8-K filed on March 20, 2007 (SEC file number 001-16477)), incorporated herein by reference to Exhibit 4.4 to Aetna Inc.'s Form 10-Q filed July 30, 2013.
4.11
Officers' Certificate pursuant to the Indenture, dated as of March 20, 2007 (incorporated by reference to Exhibit 4.2 to Coventry Health Care, Inc.'s Current Report on Form 8-K filed on March 20, 2007 (SEC file number 001-16477)), incorporated herein by reference to Exhibit 4.5 to Aetna Inc.'s Form 10-Q filed July 30, 2013.
4.12
Global Note for the 2017 Notes, dated March 20, 2007, of Coventry Health Care, Inc. (incorporated by reference to Exhibit 4.3 to Coventry Health Care, Inc.'s Current Report on Form 8-K filed on March 20, 2007 (SEC file number 001-16477)), incorporated herein by reference to Exhibit 4.6 to Aetna Inc.'s Form 10-Q filed July 30, 2013.
4.13
First Supplemental Indenture, dated as of August 27, 2007, among Coventry Health Care, Inc. and Union Bank of California, N.A., as Trustee (incorporated by reference to Exhibit 4.1 to Coventry Health Care, Inc.'s Current Report on Form 8-K filed on August 27, 2007 (SEC file number 001-16477)), incorporated herein by reference to Exhibit 4.7 to Aetna Inc.'s Form 10-Q filed July 30, 2013.
4.14
Officers' Certificate pursuant to the Indenture, dated as of August 27, 2007 (incorporated by reference to Exhibit 4.2 to Coventry Health Care, Inc.'s Current Report on Form 8-K filed on August 27, 2007 (SEC file number 001-16477)), incorporated herein by reference to Exhibit 4.8 to Aetna Inc.'s Form 10-Q filed July 30, 2013.
4.15
Global Note for the 2014 Notes, dated August 27, 2007, of Coventry Health Care, Inc. (incorporated by reference to Exhibit 4.3 to Coventry Health Care, Inc.'s Current Report on Form 8-K filed on March 20, 2007 (SEC file number 001-16477)), incorporated herein by reference to Exhibit 4.9 to Aetna Inc.'s Form 10-Q filed July 30, 2013.
4.16
Second Supplemental Indenture, dated as of June 7, 2011, among Coventry Health Care, Inc. and Union Bank, National Association, as Trustee (incorporated by reference to Exhibit 4.3 to Coventry Health Care, Inc.'s Current Report on Form 8-K filed on June 7, 2011), incorporated herein by reference to Exhibit 4.10 to Aetna Inc.'s Form 10-Q filed July 30, 2013.
4.17
Officers' Certificate pursuant to the Indenture, dated as of June 7, 2011 (incorporated by reference to Exhibit 4.4 to Coventry Health Care, Inc.'s Current Report on Form 8-K filed on June 7, 2011), incorporated herein by reference to Exhibit 4.11 to Aetna Inc.'s Form 10-Q filed July 30, 2013.
4.18
Global Note for the 2021 Notes, dated June 7, 2011, of Coventry Health Care, Inc. (incorporated by reference to Exhibit 4.5 to Coventry Health Care, Inc.'s Current Report on Form 8-K filed on June 7, 2011), incorporated herein by reference to Exhibit 4.12 to Aetna Inc.'s Form 10-Q filed July 30, 2013.
Material contracts
10.1
$1,500,000,000 Five-Year Credit Agreement dated as of March 27, 2012, incorporated herein by reference to Exhibit 99.1 to Aetna Inc.'s Form 8-K filed on March 28, 2012.
10.2
First Amendment dated as of September 24, 2012, to the $1,500,000,000 Five Year Credit Agreement dated as of March 27, 2012, incorporated herein by reference to Exhibit 99.2 to Aetna Inc.'s Form 8-K filed on September 27, 2012.
10.3
Incremental Commitment Agreement dated as of September 24, 2012, incorporated herein by reference to Exhibit 99.3 to Aetna Inc.'s Form 8-K filed on September 27, 2012.
10.4
Extension of the Maturity Date of the Five-Year Credit Agreement dated March 27, 2012, as amended, incorporated herein by reference to Exhibits 99.1 through 99.22 to Aetna Inc.'s Form 8-K filed on March 27, 2013.
10.5
Amended and Restated Aetna Inc. 2000 Stock Incentive Plan, incorporated herein by reference to Exhibit 10.4 to Aetna Inc.'s Form 10-K filed on February 27, 2009 (SEC file number 001-16095). **
10.6
Form of Aetna Inc. 2000 Stock Incentive Plan - Stock Appreciation Right Terms of Award, incorporated herein by reference to Exhibit 10.1 to Aetna Inc.'s Form 10-Q filed on October 26, 2006 (SEC file number 001-16095). **
10.7
Form of Aetna Inc. 2000 Stock Incentive Plan - Restricted Stock Unit Terms of Award, incorporated herein by reference to Exhibit 10.2 to Aetna Inc.'s Form 10-Q filed on October 26, 2006 (SEC file number 001-16095). **
10.8
Form of Aetna Inc. 2000 Stock Incentive Plan - Aetna Performance Unit Award Agreement, incorporated herein by reference to Exhibit 10.3 to Aetna Inc.'s Form 10-Q filed on October 26, 2006 (SEC file number 001-16095). **
10.9
Form of Aetna Inc. 2000 Stock Incentive Plan - Aetna Performance Stock Unit Terms of Award, incorporated herein by reference to Exhibit 10.10 to Aetna Inc.'s Form 10-K filed on February 29, 2008 (SEC file number 001-16095). **
10.10
Form of Aetna Inc. 2000 Stock Incentive Plan - Restricted Stock Unit Terms of Award, incorporated herein by reference to Exhibit 10.1 to Aetna Inc.'s Form 10-Q/A filed on August 1, 2008 (SEC file number 001-16095). **
10.11
Form of Aetna Inc. 2000 Stock Incentive Plan - Restricted Stock Unit Terms of Award (with non-compete provision), incorporated herein by reference to Exhibit 10.2 to Aetna Inc.'s Form 10-Q/A filed on August 1, 2008 (SEC file number 001-16095). **
10.12
Form of Aetna Inc. 2000 Stock Incentive Plan - Market Stock Unit Terms of Award, incorporated herein by reference to Exhibit 10.1 to Aetna Inc.'s Form 10-Q filed on April 29, 2010. **
10.13
Form of Aetna Inc. 2000 Stock Incentive Plan - Performance Stock Unit Terms of Award, incorporated herein by reference to Exhibit 10.2 to Aetna Inc.'s Form 10-Q filed on April 29, 2010. **
10.14
Form of Aetna Inc. 2000 Stock Incentive Plan - Restricted Stock Unit Terms of Award (2010, with retirement vesting), incorporated herein by reference to Exhibit 10.3 to Aetna Inc.'s Form 10-Q filed on April 29, 2010. **
10.15
Form of Aetna Inc. 2000 Stock Incentive Plan - Restricted Stock Unit Terms of Award (2010, without retirement vesting), incorporated herein by reference to Exhibit 10.4 to Aetna Inc.'s Form 10-Q filed on April 29, 2010. **
10.16
Amended and Restated Aetna Inc. 2002 Stock Incentive Plan, incorporated herein by reference to Exhibit 10.11 to Aetna Inc.'s Form 10-K filed February 27, 2009 (SEC file number 001-16095). **
10.17
Amended Aetna Inc. 2010 Stock Incentive Plan, as amended May 17, 2013, incorporated herein by reference to Exhibit 10.1 to Aetna Inc.'s Form 10-Q filed on July 30, 2013. **
10.18
Form of Aetna Inc. 2010 Stock Incentive Plan - Restricted Stock Unit Terms of Award (with non-compete provision), incorporated herein by reference to Exhibit 10.1 to Aetna Inc.'s Form 10-Q filed on April 28, 2011. **
10.19
Form of Aetna Inc. 2010 Stock Incentive Plan - Market Stock Unit Terms of Award, incorporated herein by reference to Exhibit 10.2 to Aetna Inc.'s Form 10-Q filed on April 28, 2011. **
10.20
Form of Aetna Inc. 2010 Stock Incentive Plan - Performance Stock Unit Terms of Award, incorporated herein by reference to Exhibit 10.3 to Aetna Inc.'s Form 10-Q filed on April 28, 2011. **
10.21
Form of Aetna Inc. 2010 Stock Incentive Plan - Restricted Stock Unit Terms of Award (2011, with retirement vesting), incorporated herein by reference to Exhibit 10.4 to Aetna Inc.'s Form 10-Q filed on April 28, 2011. **
10.22
Form of Aetna Inc. 2010 Stock Incentive Plan - Restricted Stock Unit Terms of Award (2011, without retirement vesting), incorporated herein by reference to Exhibit 10.5 to Aetna Inc.'s Form 10-Q filed on April 28, 2011. **
10.23
Form of Aetna Inc. 2010 Stock Incentive Plan - Stock Appreciation Right Agreement, incorporated herein by reference to Exhibit 10.6 to Aetna Inc.'s Form 10-Q filed on April 28, 2011. **
10.24
Amended and Restated Aetna Inc. 2001 Annual Incentive Plan, incorporated herein by reference to Exhibit 10.5 to Aetna Inc.'s Form 10-Q filed on April 29, 2010. **
10.25
Aetna Inc. 2010 Non-Employee Director Compensation Plan, incorporated herein by reference to Annex C to Aetna Inc.'s definitive proxy statement on Schedule 14A filed on April 12, 2010. **
10.26
Aetna Inc. Non-Employee Director Compensation Plan as Amended through December 5, 2008, incorporated herein by reference to Exhibit 10.13 to Aetna Inc.'s Form 10-K filed on February 27, 2009 (SEC file number 001-16095). **
10.27
Form of Aetna Inc. Non-Employee Director Compensation Plan - Restricted Stock Unit Agreement, incorporated herein by reference to Exhibit 10.4 to Aetna Inc.'s Form 10-Q filed on October 26, 2006 (SEC file number 001-16095). **
10.28
1999 Director Charitable Award Program, as Amended and Restated on January 25, 2008, incorporated herein by referenced to Exhibit 10.15 to Aetna Inc.'s Form 10-K filed on February 29, 2008 (SEC file number 001-16095). **
10.29
Aetna Inc. 2011 Employee Stock Purchase Plan dated as of May 20, 2011, incorporated herein by reference to Exhibit 4.4 to Aetna Inc.'s Registration Statement on Form S-8 filed on August 3, 2011. **
10.30
Amended and Restated Employment Agreement dated October 19, 2010 between Aetna Inc. and Mark T. Bertolini, incorporated herein by reference to Exhibit 10.3 to Aetna Inc.'s Form 10-Q filed November 3, 2010. **
10.31
Amendment No. 1, dated as of August 4, 2013, to Amended and Restated Employment Agreement dated October 19, 2010 between Aetna Inc. and Mark T. Bertolini, incorporated herein by reference to Exhibit 10.1 to Aetna Inc.'s Form 8-K filed on August 5, 2013. **
10.32
Letter agreement dated February 6, 2007 between Aetna Inc. and Joseph M. Zubretsky, incorporated herein by reference to Exhibit 10.29 to Aetna Inc.'s Form 10-K filed on February 27, 2007 (SEC file number 001-16095). **
10.33
Amendment No. 1 to Employment Agreement dated as of December 17, 2008 between Aetna Inc. and Joseph M. Zubretsky, incorporated herein by reference to Exhibit 10.23 to Aetna Inc.'s Form 10-K filed on February 27, 2009 (SEC file number 001-16095). **
10.34
Letter agreement dated July 20, 2000 between Aetna Inc. and William J. Casazza, incorporated herein by reference to Exhibit 10.2 to Aetna Inc.'s Form 10-Q filed on April 24, 2008 (SEC file number 001-16095). **
10.35
Amended and Restated Employment Agreement, dated as of December 21, 2004, between ActiveHealth Management, Inc. and Lonny Reisman, M.D., incorporated herein by reference to Exhibit 10.1 to Aetna Inc.'s Form 10-Q filed on April 29, 2009. **
10.36
Employment Agreement Amendment, dated as of May 12, 2005, among Aetna Inc., ActiveHealth Management, Inc. and Lonny Reisman, M.D., incorporated herein by reference to Exhibit 10.2 to Aetna Inc.'s Form 10-Q filed on April 29, 2009. **
10.37
Amendment No. 2 to Employment Agreement, dated as of December 31, 2008, between Aetna Inc. and Lonny Reisman, M.D., incorporated herein by reference to Exhibit 10.3 to Aetna Inc.'s Form 10-Q filed on April 29, 2009. **
10.38
Letter agreement dated March 23, 2011 between Aetna Life Insurance Company. and Shawn M. Guertin, incorporated herein by reference to Exhibit 10.1 to Aetna Inc.'s Form 10-Q filed on April 30, 2013. **
10.39
Letter agreement dated May 18, 2012 between Aetna Life Insurance Company and Karen S. Rohan, incorporated herein by reference to Exhibit 10.3 to Aetna Inc.'s Form 10-Q filed on April 30, 2013. **
10.40
Letter agreement dated February 13, 2012 between Aetna Life Insurance Company and Kristi Ann Matus, incorporated herein by reference to Exhibit 10.2 to Aetna Inc.'s Form 10-Q filed on April 30, 2013. **
10.41
Separation Agreement dated July 25, 2013 between Kristi Ann Matus and Aetna Life Insurance Company, incorporated herein by reference to Exhibit 10.2 to Aetna Inc.'s Form 10-Q filed on July 30, 2013. **
10.42
Descriptions of certain arrangements not embodied in formal documents as described under the headings “2013 Nonmanagement Director Compensation” and “Additional Director Compensation Information” are incorporated herein by reference to the Proxy Statement (when filed). **
Statement re: computation of per share earnings
11.1
“Computation of per share earnings” is incorporated herein by reference to Note 4 of Notes to Consolidated Financial Statements on page 97 of the Annual Report.
Statement re: computation of ratios
12.1
Computation of ratio of earnings to fixed charges.
Annual report to security holders
13.1
Management's Discussion and Analysis of Financial Condition and Results of Operations, Selected Financial Data, Consolidated Financial Statements, Notes to Consolidated Financial Statements, Management's Report on Internal Control Over Financial Reporting, Management's Responsibility for Financial Statements, Audit Committee Oversight, Report of Independent Registered Public Accounting Firm, Quarterly Data (unaudited) and Corporate Performance Graph are incorporated herein by reference to the Annual Report and filed herewith in electronic format.
Subsidiaries of the registrant
21.1
Subsidiaries of Aetna Inc.
Consents of experts and counsel
23.1
Consent of Independent Registered Public Accounting Firm.
Power of Attorney
24.1
Power of Attorney.
Rule 13a - 14(a)/15d - 14(e) Certifications
31.1
Certification.
31.2
Certification.
Section 1350 Certifications
32.1
Certification.
32.2
Certification.
XBRL Documents
101.INS
XBRL Instance Document.
101.SCH
XBRL Taxonomy Extension Schema.
101.CAL
XBRL Taxonomy Extension Calculation Linkbase.
101.DEF
XBRL Taxonomy Extension Definition Linkbase.
101.LAB
XBRL Taxonomy Extension Label Linkbase.
101.PRE
XBRL Taxonomy Extension Presentation Linkbase.
*
Exhibits other than those listed are omitted because they are not required to be listed or are not applicable. Copies of exhibits, including exhibits that are not required to be listed, will be furnished without charge upon written request to the Office of the Corporate Secretary, Aetna Inc., 151 Farmington Avenue, Hartford, Connecticut 06156.
**
Management contract or compensatory plan or arrangement.
Index to Financial Statement Schedule
Page
Report of Independent Registered Public Accounting Firm
Schedule I: Financial Information of Aetna Inc. (Parent Company Only):
Statements of Income
Statements of Comprehensive Income
Balance Sheets
Statements of Shareholders' Equity
Statements of Cash Flows
Notes to Financial Statements
Report of Independent Registered Public Accounting Firm
The Board of Directors and Shareholders
Aetna Inc.:
Under the date of February 28, 2014, we reported on the consolidated balance sheets of Aetna Inc. and subsidiaries (the “Company”) as of December 31, 2013 and 2012, and the related consolidated statements of income, comprehensive income, shareholders' equity and cash flows for each of the years in the three-year period ended December 31, 2013, as contained in the Annual Report on Form 10-K for the year ended December 31, 2013. In connection with our audits of the aforementioned consolidated financial statements, we also audited the related financial statement schedule listed in the accompanying index. The financial statement schedule is the responsibility of the Company's management. Our responsibility is to express an opinion on the financial statement schedule based on our audits.
In our opinion, such financial statement schedule, when considered in relation to the basic consolidated financial statements taken as a whole, presents fairly, in all material respects, the information set forth therein.
/s/ KPMG LLP
Hartford, Connecticut
February 28, 2014
Schedule I - Financial Information of Aetna Inc.
Aetna Inc. (Parent Company Only)
Statements of Income
For the Years Ended December 31,
(Millions)
Net investment income
$
3.1
$
1.5
$
.8
Other income
-
-
.2
Net realized capital gains
2.8
-
.4
Total revenue
5.9
1.5
1.4
Operating expenses
142.7
136.1
157.8
Interest expense
312.3
268.8
246.9
Loss on early extinguishment of long-term debt
-
84.9
-
Total expenses
455.0
489.8
404.7
Loss before income tax benefit and equity in earnings of affiliates, net
(449.1
)
(488.3
)
(403.3
)
Income tax benefit
142.3
156.1
140.1
Equity in earnings of affiliates, net (1)
2,220.4
1,990.1
2,248.9
Net income attributable to Aetna
$
1,913.6
$
1,657.9
$
1,985.7
(1)
Includes after-tax amortization of other acquired intangible assets of $139.5 million, $92.3 million and $78.5 million for the years ended December 31, 2013, 2012 and 2011, respectively.
Refer to accompanying Notes to Financial Statements.
Aetna Inc. (Parent Company Only)
Statements of Comprehensive Income
For the Years Ended December 31,
(Millions)
Net income attributable to Aetna
$
1,913.6
$
1,657.9
$
1,985.7
Other comprehensive income (loss), net of tax:
Previously impaired debt securities: (1)
Net unrealized (losses) gains
($(72.6), $3.7, and $3.7 pretax)
(47.2
)
2.4
2.4
Less: reclassification of (losses) gains to earnings
($(37.1), $5.1, and $29.7 pretax)
(24.1
)
3.3
19.3
Total previously impaired debt securities (1)
(23.1
)
(.9
)
(16.9
)
All other securities:
Net unrealized (losses) gains
($(803.2), $468.3, and $518.8 pretax)
(522.1
)
304.4
337.2
Less: reclassification of (losses) gains to earnings
($(36.5), $113.8, and $180.3 pretax)
(23.7
)
74.4
117.2
Total all other securities
(498.4
)
230.0
220.0
Foreign currency and derivatives:
Net unrealized gains (losses)
($40.6, $1.4, and $(14.2) pretax)
26.4
.9
(9.2
)
Less: reclassification of losses to earnings
($(5.4), $(5.0), and $(4.3) pretax)
(3.5
)
(3.3
)
(2.8
)
Total foreign currency and derivatives
29.9
4.2
(6.4
)
Pension and other postretirement benefit (“OPEB”) plans:
Unrealized net actuarial gains (losses) arising during the period
($869.3, $(189.8), and $(402.6) pretax)
565.1
(123.4
)
(261.7
)
Amortization of net actuarial losses
($(77.7), ($74.7), and ($63.2) pretax)
50.5
48.6
41.1
Amortization of prior service credit
($4.1, $4.1, and $4.1 pretax)
(2.7
)
(2.7
)
(2.7
)
Total pension and OPEB plans
612.9
(77.5
)
(223.3
)
Other comprehensive income (loss)
121.3
155.8
(26.6
)
Comprehensive income attributable to Aetna
$
2,034.9
$
1,813.7
$
1,959.1
(1)
Represents unrealized (losses) gains on the non-credit related component of impaired debt securities that we do not intend to sell and subsequent changes in the fair value of any previously impaired debt security.
Refer to accompanying Notes to Financial Statements.
Aetna Inc. (Parent Company Only)
Balance Sheets
At December 31,
(Millions)
Assets
Current assets:
Cash and cash equivalents
$
187.6
$
2,206.7
Investments
26.9
175.2
Other receivables
62.8
11.0
Income taxes receivable
29.7
64.9
Deferred income taxes
45.4
43.2
Other current assets
13.9
32.3
Total current assets
366.3
2,533.3
Investment in affiliates (1)
20,627.1
15,513.2
Long-term investments
48.4
8.2
Deferred income taxes
72.1
419.8
Other long-term assets
468.0
47.3
Total assets
$
21,581.9
$
18,521.8
Liabilities and shareholders' equity
Current liabilities:
Accrued expenses and other current liabilities
431.5
426.9
Total current liabilities
431.5
426.9
Long-term debt
6,488.1
6,481.3
Employee benefit liabilities
542.6
1,147.4
Income taxes payable
4.0
3.2
Other long-term liabilities
37.5
33.8
Total liabilities
7,503.7
8,092.6
Shareholders' equity:
Common stock ($.01 par value; 2.6 billion shares authorized and 362.2 million shares issued
and outstanding in 2013; 2.6 billion shares authorized and 327.6 million shares issued and
outstanding in 2012) and additional paid-in capital
4,382.2
1,095.3
Retained earnings
10,555.4
10,343.9
Accumulated other comprehensive loss
(912.1
)
(1,033.4
)
Total Aetna shareholders' equity
14,025.5
10,405.8
Non-controlling interests
52.7
23.4
Total equity
14,078.2
10,429.2
Total liabilities and shareholders' equity
$
21,581.9
$
18,521.8
(1)
Includes goodwill and other acquired intangible assets of $12.3 billion and $7.0 billion at December 31, 2013 and 2012, respectively.
Refer to accompanying Notes to Financial Statements.
Aetna Inc. (Parent Company Only)
Statements of Shareholders' Equity
Attributable to Aetna
(Millions)
Number of
Common
Shares
Outstanding
Common
Stock and
Additional
Paid-in
Capital
Retained
Earnings
Accumulated
Other
Comprehensive
Loss
Total Aetna
Shareholders'
Equity
Non-Controlling Interests
Total
Equity
Balance at December 31, 2010
$
384.4
$
651.5
$
10,401.9
$
(1,162.6
)
$
9,890.8
$
26.5
$
9,917.3
Net income
-
-
1,985.7
-
1,985.7
1.2
1,986.9
Other decreases in non-
controlling interests
-
-
-
-
-
(3.3
)
(3.3
)
Other comprehensive loss
-
-
-
(26.6
)
(26.6
)
-
(26.6
)
Common shares issued for benefit plans,
including tax benefits
10.4
311.7
-
-
311.7
-
311.7
Repurchases of common shares
(45.1
)
(.4
)
(1,812.6
)
-
(1,813.0
)
-
(1,813.0
)
Dividends declared
-
-
(228.4
)
-
(228.4
)
-
(228.4
)
Balance at December 31, 2011
349.7
962.8
10,346.6
(1,189.2
)
10,120.2
24.4
10,144.6
Net income
-
-
1,657.9
-
1,657.9
1.9
1,659.8
Other decreases in non-
controlling interests
-
-
-
-
-
(2.9
)
(2.9
)
Other comprehensive income
-
-
-
155.8
155.8
-
155.8
Common shares issued for benefit plans,
including tax benefits
10.2
132.8
-
-
132.8
-
132.8
Repurchases of common shares
(32.3
)
(.3
)
(1,417.2
)
-
(1,417.5
)
-
(1,417.5
)
Dividends declared
-
-
(243.4
)
-
(243.4
)
-
(243.4
)
Balance at December 31, 2012
327.6
1,095.3
10,343.9
(1,033.4
)
10,405.8
23.4
10,429.2
Net income (loss)
-
-
1,913.6
-
1,913.6
(1.7
)
1,911.9
Other (decreases) increases in non-
controlling interests
-
(8.7
)
-
-
(8.7
)
31.0
22.3
Other comprehensive income
-
-
-
121.3
121.3
-
121.3
Common shares issued to
acquire Coventry
52.2
3,064.6
-
-
3,064.6
-
3,064.6
Common shares issued for benefit plans,
including tax benefits
5.4
231.2
-
-
231.2
-
231.2
Repurchases of common shares
(23.0
)
(.2
)
(1,407.5
)
-
(1,407.7
)
-
(1,407.7
)
Dividends declared
-
-
(294.6
)
-
(294.6
)
-
(294.6
)
Balance at December 31, 2013
362.2
$
4,382.2
$
10,555.4
$
(912.1
)
$
14,025.5
$
52.7
$
14,078.2
Refer to accompanying Notes to Financial Statements.
Aetna Inc. (Parent Company Only)
Statements of Cash Flows
For the Years Ended December 31,
(Millions)
Cash flows from operating activities:
Net income attributable to Aetna
$
1,913.6
$
1,657.9
$
1,985.7
Adjustments to reconcile net income including non-controlling interests to
net cash (used for) provided by operating activities:
Loss on early extinguishment of long-term debt
-
84.9
-
Equity earnings of affiliates (1)
(2,220.4
)
(1,990.1
)
(2,248.9
)
Stock-based compensation expense
127.1
122.2
141.4
Net realized capital gains
(2.8
)
-
(.4
)
Net change in other assets and other liabilities
(65.5
)
48.3
388.7
Net cash (used for) provided by operating activities
(248.0
)
(76.8
)
266.5
Cash flows from investing activities:
Proceeds from sales and maturities of investments
701.5
112.8
51.2
Cost of investments
(532.0
)
(249.5
)
-
Dividends received from affiliates, net
2,625.0
2,062.5
1,768.7
Cash used for acquisitions (2)
(3,014.3
)
-
(716.1
)
Net cash (used for) provided by investing activities
(219.8
)
1,925.8
1,103.8
Cash flows from financing activities:
Repayment of long-term debt
-
(277.2
)
(900.0
)
Issuance of long-term debt
-
2,664.8
480.1
Net (repayment) issuance of short-term debt
-
(425.9
)
425.9
Common shares issued under benefit plans
11.8
(44.5
)
125.5
Stock-based compensation tax benefits
83.4
50.3
38.5
Common shares repurchased
(1,407.7
)
(1,417.5
)
(1,813.0
)
Collateral held on interest rate swaps
39.9
9.2
(2.0
)
Dividends paid to shareholders
(278.7
)
(239.1
)
(167.2
)
Net cash (used for) provided by financing activities
(1,551.3
)
320.1
(1,812.2
)
Net (decrease) increase in cash and cash equivalents
(2,019.1
)
2,169.1
(441.9
)
Cash and cash equivalents, beginning of period
2,206.7
37.6
479.5
Cash and cash equivalents, end of period
$
187.6
$
2,206.7
$
37.6
Supplemental cash flow information:
Interest paid
$
301.4
$
241.9
$
254.0
Income taxes refunded
294.0
282.3
247.6
(1)
Includes after-tax amortization of other acquired intangible assets of $139.5 million, $92.3 million and $78.5 million for the years ended December 31, 2013, 2012 and 2011, respectively.
(2)
Represents parent company cash used primarily for the Coventry acquisition.
Refer to accompanying Notes to Financial Statements.
Aetna Inc. (Parent Company Only)
Notes to Financial Statements
1. Organization
The financial statements reflect financial information for Aetna Inc. (a Pennsylvania corporation) only (the “Parent Company”). The financial information presented herein includes the balance sheet of the Parent Company as of December 31, 2013 and 2012 and the related statements of income, comprehensive income, shareholders' equity and cash flows for the years ended December 31, 2013, 2012 and 2011. The accompanying financial statements should be read in conjunction with the consolidated financial statements and notes thereto in the Annual Report.
2. Summary of Significant Accounting Policies
Refer to Note 2 of Notes to Consolidated Financial Statements, beginning on page 83 of the Annual Report, for the summary of significant accounting policies.
3. Dividends
Gross cash dividends received from subsidiaries and included in net cash provided by investing activities in the Statements of Cash Flows were $2.5 billion, $1.7 billion and $2.5 billion in 2013, 2012 and 2011, respectively.
4. Acquisitions and Dispositions
Refer to Note 3 of Notes to Consolidated Financial Statements, on page 91 of the Annual Report, for a description of acquisitions and dispositions.
5. Other Comprehensive Income (Loss)
Refer to Note 9 of Notes to Consolidated Financial Statements, beginning on page 106 of the Annual Report, for a description of accumulated other comprehensive income (loss).
6. Debt
Long-term debt on the balance sheet of the parent company excludes long-term debt of a subsidiary acquired in the Coventry acquisition. Refer to Note 14 of Notes to Consolidated Financial Statements, on page 126 of the Annual Report, for a description of Aetna's total debt.
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date:
February 28, 2014
Aetna Inc.
By: /s/ Rajan Parmeswar
Rajan Parmeswar
Vice President, Controller and Chief Accounting Officer
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
Signer
Title
Date
/s/ Mark T. Bertolini
Chairman, Chief Executive Officer,
February 28, 2014
Mark T. Bertolini
President and Director
(Principal Executive Officer)
/s/ Shawn M. Guertin
Executive Vice President and
February 28, 2014
Shawn M. Guertin
Chief Financial Officer
(Principal Financial Officer)
/s/ Rajan Parmeswar
Vice President, Controller and
February 28, 2014
Rajan Parmeswar
Chief Accounting Officer
(Principal Accounting Officer)
Fernando Aguirre *
Director
Frank M. Clark *
Director
Betsy Z. Cohen *
Director
Molly J. Coye, M.D. *
Director
Roger N. Farah *
Director
Barbara Hackman Franklin *
Director
Jeffrey E. Garten *
Director
Ellen M. Hancock *
Director
Richard J. Harrington *
Director
Edward J. Ludwig *
Director
Joseph P. Newhouse *
Director
* By: /s/ Rajan Parmeswar
Rajan Parmeswar
Attorney-in-fact
February 28, 2014
INDEX TO EXHIBITS
Exhibit
Filing
Number
Description of Exhibit
Method
Statement re: computation of ratios
12.1
Computation of ratio of earnings to fixed charges.
Electronic
Annual report to security holders
13.1
Management's Discussion and Analysis of Financial Condition and Results of Operations, Selected Financial Data, Consolidated Financial Statements, Notes to Consolidated Financial Statements, Management's Report on Internal Control Over Financial Reporting, Management's Responsibility for Financial Statements, Audit Committee Oversight, Report of Independent Registered Public Accounting Firm, Quarterly Data (unaudited) and Corporate Performance Graph sections of the Annual Report.
Electronic
Subsidiaries of the registrant
21.1
Subsidiaries of Aetna Inc.
Electronic
Consents of experts and counsel
23.1
Consent of Independent Registered Public Accounting Firm.
Electronic
Power of Attorney
24.1
Power of Attorney.
Electronic
Rule 13a - 14(a)/15d - 14(e) Certifications
31.1
Certification.
Electronic
31.2
Certification.
Electronic
Section 1350 Certifications
32.1
Certification.
Electronic
32.2
Certification.
Electronic
XBRL Documents
101.INS
XBRL Instance Document.
101.SCH
XBRL Taxonomy Extension Schema.
101.CAL
XBRL Taxonomy Extension Calculation Linkbase.
101.DEF
XBRL Taxonomy Extension Definition Linkbase.
101.LAB
XBRL Taxonomy Extension Label Linkbase.
101.PRE
XBRL Taxonomy Extension Presentation Linkbase.